WVY-25929-28876
3 vaccinations
4 coded responses
9 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 774 / TX
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Moderna
- 2021-01-15
- 2021-01-17
- 2021-01-18
- 2021-01-21
-
2021-02-12
Dose 2 — Moderna
-
2021-02-13
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Heart palpitationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-13
-
2022-01-11
Dose 3 — Pfizer-BioNTech
-
2022-02-13
Survey response — 12 months, dose 2MedDRA: Vertigo — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: VertigoMedDRA releases: 2024-11 · check-in free text available
-
2022-02-13
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-17
- 2022-02-22
-
2022-07-12
Survey response — 6 months, dose 3MedDRA: Ageusia, Anosmia, Arthralgia, Pain in extremity, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Arthritis type symptoms in hands. Haven't been able to smell or taste that good since booster #1. Never tested positive for Covid.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-12
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-13
Call successfulDoes not wish to fill out VAERS report
-
2022-07-13
Call successfulDoes not wish to fill out VAERS report
-
2023-01-11
Survey response — 12 months, dose 3MedDRA: Chronic sinusitis, Sinus operation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-01-11
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2023-01-12
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2022-01-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-13 | Successful 2022-07-13 |
Does not wish to fill out VAERS report |
| 2022-07-12 | Successful 2022-07-13 |
Does not wish to fill out VAERS report |
| 2023-01-11 | Successful 2023-01-12 |
Participant prefers to complete VAERS report online |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Heart palpitations
Release 11 — 12 months, dose 2
Symptoms: Vertigo
Release 12 — 6 months, dose 3
Symptoms: Arthritis type symptoms in hands. Haven't been able to smell or taste that good since booster #1. Never tested positive for Covid.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Chronic sinusitis | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinus operation | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release